8.62
+0.05
+(0.58%)
At close: January 15 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-37,107.00
-18,849.00
-48,611.00
-47,621.00
-23,365.00
Investing Cash Flow
-135,972.00
-148,454.00
-11,094.00
-6,397.00
-626.00
Financing Cash Flow
616.00
2,691.00
2,311.00
270,795.00
96,236.00
End Cash Position
31,400.00
177,026.00
341,337.00
399,269.00
182,584.00
Income Tax Paid Supplemental Data
792.00
808.00
684.00
--
--
Interest Paid Supplemental Data
--
--
--
389.00
625.00
Capital Expenditure
-4,866.00
-3,841.00
-11,614.00
-13,675.00
-3,930.00
Issuance of Capital Stock
--
--
--
269,718.00
91,404.00
Repayment of Debt
--
--
--
-7,738.00
-75.00
Free Cash Flow
-41,973.00
-22,690.00
-60,225.00
-61,296.00
-27,295.00
12/31/2020 - 12/7/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LAB Standard BioTools Inc.
2.0200
+0.50%
CTKB Cytek Biosciences, Inc.
5.68
-21.76%
MASS 908 Devices Inc.
2.9100
+46.97%
CVRX CVRx, Inc.
17.00
+5.26%
IRTC iRhythm Technologies, Inc.
103.16
+4.19%
NPCE NeuroPace, Inc.
12.00
+1.35%
AXGN Axogen, Inc.
18.73
+2.69%
NVRO Nevro Corp.
4.2400
+14.59%
ESTA Establishment Labs Holdings Inc.
34.65
+4.52%
RXST RxSight, Inc.
31.32
+4.12%